Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.

Status:

WITHDRAWN

Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.

Lead Sponsor:

Melbourne Health

Conditions:

Renal Impairment After Cardiac Surgery

Eligibility:

All Genders

18+ years

Phase:

Brief Summary

The purpose of the project is to test whether or not the commonly used medication frusemide, given after heart surgery, and aiming to increase urinary output can have an effect on kidney function.

Detailed Description

All patients will receive standard supportive care based on current established management practice of cardio-thoracic patients. The only difference in treatment will be the randomisation of patients ...

Eligibility Criteria

Inclusion

All patients admitted for cardiac surgery will be assessed for eligibility. Participants will be approached for inclusion, from the pre-admission clinics and wards of the Cardiothoracic surgery unit. Potential participants will be identified by the daily review of planned cardiothoracic surgery schedule.

Exclusion

Already in established dialysis dependent chronic renal failure.
Known allergy to frusemide
Age \< 18 years
Pregnant

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00246675

Last Update

April 27 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)